Weight changes in users of depot medroxyprogesterone acetate intramuscular compared with women using nonhormonal contraception

被引：0
|
作者：
Rice, VM [1 ]
Weiss, R [1 ]
Kaunitz, AM [1 ]
机构：
[1] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2005年 / 105卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：58S / 59S
页数：2
相关论文
共 50 条
  • [31] Bone mineral density change and patient satisfaction - Subcutaneous compared with intramuscular depot medroxyprogesterone acetate
    Kaunitz, Andrew M.
    Ross, Douglas
    Wolter, Kevin
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 109S - 109S
  • [32] Bone density changes in young women in Uganda using tenofovir-based HIV preexposure prophylaxis and depot medroxyprogesterone acetate contraception
    Heffron, Renee
    Muwonge, Timothy R.
    Thomas, Katherine K.
    Zewdie, Kidist
    Ssebuliba, Timothy
    Stein, Gabrielle
    Morrison, Susan
    Badaru, Josephine
    Nakyanzi, Agnes
    Bambia, Felix
    Mugwanya, Kenneth
    Wyatt, Christina
    Matovu, Flavia
    Yin, Michael T.
    Mujugira, Andrew
    AIDS, 2025, 39 (02) : 123 - 132
  • [33] Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users
    Thurman, Andrea R.
    Schwartz, Jill L.
    Brache, Vivian
    Chen, Beatrice A.
    Chandra, Neelima
    Kashuba, Angela D. M.
    Weiner, Debra H.
    Mauck, Christine
    Doncel, Gustavo F.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (01) : 79 - 88
  • [34] LONG-ACTING INJECTABLE CONTRACEPTION WITH DEPOT MEDROXYPROGESTERONE ACETATE
    KAUNITZ, AM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (05) : 1543 - 1549
  • [35] Use of Depot Medroxyprogesterone Acetate Contraception and Incidence of Bone Fracture
    Lanza, Lee L.
    McQuay, Lisa J.
    Rothman, Kenneth J.
    Bone, Henry G.
    Kaunitz, Andrew M.
    Harel, Zeev
    Ataher, Quazi
    Ross, Douglas
    Arena, Philip L.
    Wolter, Kevin D.
    OBSTETRICS AND GYNECOLOGY, 2013, 121 (03): : 593 - 600
  • [36] Injectable depot medroxyprogesterone acetate contraception: An update for US clinicians
    Kaunitz, AM
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 1998, 43 (02): : 73 - 83
  • [37] Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer
    Kaunitz, AM
    JOURNAL OF REPRODUCTIVE MEDICINE, 1996, 41 (05) : 419 - 425
  • [38] Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception
    Overton, Edgar Turner
    Shacham, Enbal
    Singhatiraj, Ekachai
    Nurutdinova, Diana
    CONTRACEPTION, 2008, 78 (02) : 125 - 130
  • [39] Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir: Increased Tenofovir Diphosphate in Depot Medroxyprogesterone Acetate Users
    Thurman, Andrea
    Schwartz, Jill
    Brache, Vivian
    Chen, Beatrice
    Chandra, Neelima
    Kashuba, Angela
    Weiner, Debra
    Mauck, Christine
    Doncel, Gustavo F.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 342 - 342
  • [40] Is DEXA scanning justified in women using depot medroxyprogesterone acetate as contraception? An audit of practice in Glasgow Royal Infirmary
    Dargie, R
    Galloway, P
    McLellan, A
    Bessant, R
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S32 - S32
12345